Generating AI analysis...
AI Earnings Analysis
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Revenue | $4.66M | $1.14M | +310.40% |
Operating Income | $-76.16M | $-66.99M | -13.69% |
Net Income | $-76.09M | $-61.95M | -22.82% |
EPS (Basic) | $-0.92 | $-0.76 | -21.05% |
EPS (Diluted) | $-0.92 | $-0.76 | -21.05% |
R&D Expense | $26.59M | $48.79M | -45.49% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Total Assets | $263.65M | $440.35M | -40.13% |
Current Assets | $224.84M | $305.56M | -26.41% |
Total Liabilities | $201.23M | $145.95M | +37.88% |
Current Liabilities | $73.11M | $66.49M | +9.97% |
Stockholders' Equity | $62.42M | $294.4M | -78.80% |
Cash & Equivalents | $138.69M | $69.23M | +100.34% |
Long-Term Debt | $49.58M | — | — |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Cash Flow | $-47.8M | $-49.87M | +4.16% |
Investing Cash Flow | $56.39M | $-4.75M | +1288.35% |
Financing Cash Flow | $-1.44M | $192,000 | -848.44% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Margin | -1635.1% | -5902.3% | +4267.19% |
Net Margin | -1633.5% | — | — |
ROE | -121.9% | — | — |
ROA | -28.9% | — | — |
Current Ratio | $3.075 | — | — |
Debt to Equity | $3.224 | — | — |
Other companies in Biotechnology